药物洗脱支架治疗非常小的冠状动脉疾病患者的一年临床结果：印度人群中的观察性研究。
One-year clinical outcomes in patients with very small coronary artery disease treated with drug-eluting stents: An observational study in the Indian population.
机构信息
Department of Cardiology, Hardas Heart Care, Pune, India; Department of Cardiology, Galaxy Hardas Heart Care, Pune, India; Department of Cardiology, Poona Hospital and Research Centre, Pune, India; Consultant Interventional Cardiologist and Electrophysiologist, Department of Cardiology, Ruby Hall Clinic, Pune, India.
Department of Cardiology, Hardas Heart Care, Pune, India; Department of Cardiology, Ruby Hall Clinic, Pune, India.
出版信息
Indian Heart J. 2021 Nov-Dec;73(6):729-732. doi: 10.1016/j.ihj.2021.09.007. Epub 2021 Sep 20.
Abstract
Percutaneous coronary intervention (PCI) in very small vessel coronary arteries is challenging due to adverse short-term as well as long-term outcomes. This single-arm, open-label, observational study assessed 1-year clinical outcomes of drug-eluting stents (DES) in Indian patients undergoing PCI for symptomatic very small-calibre coronary artery disease. It enrolled 66 Indian patients with 74 very small coronary artery lesions (reference vessel diameter: ≥2.0 and ≤ 2.25 mm); eligible for implantation with 2.25 mm DES. The primary endpoint of major adverse cardiovascular events (MACE) was 3.0% indicating favourable 1-year clinical outcomes of DES in very small coronary artery lesions in Indian patients.
摘要
经皮冠状动脉介入治疗（PCI）在非常小的血管冠状动脉中具有挑战性，因为存在不良的短期和长期结果。这项单臂、开放标签、观察性研究评估了在接受 PCI 治疗有症状的非常小口径冠状动脉疾病的印度患者中使用药物洗脱支架（DES）的 1 年临床结果。它纳入了 66 名印度患者，共 74 个非常小的冠状动脉病变（参考血管直径：≥2.0 且≤2.25 毫米）；适合植入 2.25 毫米 DES。主要不良心血管事件（MACE）的主要终点为 3.0%，表明在印度患者的非常小冠状动脉病变中，DES 的 1 年临床结果良好。
相似文献
1
One-year clinical outcomes in patients with very small coronary artery disease treated with drug-eluting stents: An observational study in the Indian population.药物洗脱支架治疗非常小的冠状动脉疾病患者的一年临床结果：印度人群中的观察性研究。
Indian Heart J. 2021 Nov-Dec;73(6):729-732. doi: 10.1016/j.ihj.2021.09.007. Epub 2021 Sep 20.
2
Safety and effectiveness of drug-eluting stents versus bare-metal stents in elderly patients with small coronary vessel disease.药物洗脱支架与金属裸支架治疗老年小血管病变患者的安全性和有效性。
Arch Cardiovasc Dis. 2013 Nov;106(11):554-61. doi: 10.1016/j.acvd.2013.06.056. Epub 2013 Nov 11.
3
Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.经皮冠状动脉介入治疗开口/中段病变与无保护左主干冠状动脉分叉病变的长期临床结局：DELTA 注册研究（左主干冠状动脉疾病药物洗脱支架）：一项多中心注册研究，评估经皮冠状动脉介入治疗与冠状动脉旁路移植术治疗左主干的疗效。
JACC Cardiovasc Interv. 2013 Dec;6(12):1242-9. doi: 10.1016/j.jcin.2013.08.005.
4
Outcomes of small coronary artery stenting with bare-metal stents versus drug-eluting stents: results from the NHLBI Dynamic Registry.裸金属支架与药物洗脱支架治疗小冠状动脉狭窄的结果：来自 NHLBI 动态注册研究的结果。
Catheter Cardiovasc Interv. 2014 Feb;83(2):192-200. doi: 10.1002/ccd.23194. Epub 2013 Oct 24.
5
Long-term effects of drug-eluting stents versus bare metal stents on patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: outcomes of 3-year clinical follow-up.药物洗脱支架与金属裸支架对行直接经皮冠状动脉介入治疗的急性 ST 段抬高型心肌梗死患者的长期影响：3 年临床随访结果。
Chin Med J (Engl). 2012 Aug;125(16):2803-6.
6
The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials.血管成像在常规经皮冠状动脉介入治疗中的作用：金属裸支架和药物洗脱支架试验的荟萃分析。
Cardiovasc Ther. 2015 Dec;33(6):360-6. doi: 10.1111/1755-5922.12160.
7
Bioabsorbable polymer drug-eluting stents with 4-month dual antiplatelet therapy versus durable polymer drug-eluting stents with 12-month dual antiplatelet therapy in patients with left main coronary artery disease: the IDEAL-LM randomised trial.左主干冠状动脉疾病患者中使用 4 个月双联抗血小板治疗的可生物吸收聚合物药物洗脱支架与使用 12 个月双联抗血小板治疗的耐用聚合物药物洗脱支架的比较：IDEAL-LM 随机试验。
EuroIntervention. 2022 Apr 22;17(18):1467-1476. doi: 10.4244/EIJ-D-21-00514.
8
Clinical outcomes of "complete, partially complete, and incomplete" revascularisation at five-year follow-up after percutaneous intervention of unprotected left main coronary artery disease with drug-eluting stents.药物洗脱支架经皮介入治疗无保护左主干冠状动脉疾病后五年随访时“完全、部分完全和不完全”血运重建的临床结局
EuroIntervention. 2016 Oct 10;12(8):e957-e963. doi: 10.4244/EIJY15M12_06.
9
A clinical and angiographic study of the XIENCE V everolimus-eluting coronary stent system in the treatment of patients with multivessel coronary artery disease: the EXECUTIVE trial (EXecutive RCT: evaluating XIENCE V in a multi vessel disease).XIENCE V 依维莫司洗脱冠状动脉支架系统治疗多支冠状动脉疾病患者的临床和血管造影研究：EXECUTIVE 试验（EXecutive RCT：评估 XIENCE V 在多支血管疾病中的应用）。
JACC Cardiovasc Interv. 2013 Oct;6(10):1012-22. doi: 10.1016/j.jcin.2013.05.016. Epub 2013 Sep 18.
10
In-hospital and one year outcomes with drug-eluting versus bare metal stents in large native coronary arteries: a report from the Evaluation of Drug-Eluting Stents and Ischemic Events registry.药物洗脱支架与裸金属支架在大.native 冠状动脉中的院内和一年结果：来自药物洗脱支架和缺血事件评估登记处的报告。
Catheter Cardiovasc Interv. 2013 Oct 1;82(4):E356-64. doi: 10.1002/ccd.24451. Epub 2013 May 25.
本文引用的文献
1
Update on Antithrombotic Therapy after Percutaneous Coronary Intervention.经皮冠状动脉介入治疗后抗栓治疗的最新进展
Intern Med. 2020 Feb 1;59(3):311-321. doi: 10.2169/internalmedicine.3685-19. Epub 2019 Oct 7.
2
Outcomes in Patients Treated With Thin-Strut, Very Thin-Strut, or Ultrathin-Strut Drug-Eluting Stents in Small Coronary Vessels: A Prespecified Analysis of the Randomized BIO-RESORT Trial.小血管病变患者中应用薄支架、超薄支架或极薄支架药物洗脱支架的临床结局：随机 BIO-RESORT 试验的预设分析。
JAMA Cardiol. 2019 Jul 1;4(7):659-669. doi: 10.1001/jamacardio.2019.1776.
3
Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document.经皮冠状动脉介入治疗临床试验终点标准化定义：学术研究联合会-2 共识文件。
Eur Heart J. 2018 Jun 14;39(23):2192-2207. doi: 10.1093/eurheartj/ehy223.
4
Treatment of Very Small De Novo Coronary Artery Disease With 2.0 mm Drug-Coated Balloons Showed 1-Year Clinical Outcome Comparable With 2.0 mm Drug-Eluting Stents.使用2.0毫米药物涂层球囊治疗非常小的初发冠状动脉疾病显示，1年临床结果与2.0毫米药物洗脱支架相当。
J Invasive Cardiol. 2018 Jul;30(7):256-261. Epub 2018 Apr 15.
5
Coronary artery dimensions in normal Indians.正常印度人的冠状动脉尺寸
Indian Heart J. 2017 Jul-Aug;69(4):512-514. doi: 10.1016/j.ihj.2017.01.009. Epub 2017 Jan 20.
6
First Report of the Resolute Onyx 2.0-mm Zotarolimus-Eluting Stent for the Treatment of Coronary Lesions With Very Small Reference Vessel Diameter.首例 Resolute Onyx 2.0-mm 载唑拉莫司药物涂层支架治疗小参考血管直径冠状动脉病变
JACC Cardiovasc Interv. 2017 Jul 24;10(14):1381-1388. doi: 10.1016/j.jcin.2017.05.004.
7
The outcomes of patients with very small coronary artery disease treated with thin strut cobalt chromium bare metal stents: an observational study.薄支撑钴铬合金裸金属支架治疗微小冠状动脉疾病患者的结局：一项观察性研究。
Springerplus. 2016 Sep 27;5(1):1668. doi: 10.1186/s40064-016-3350-7. eCollection 2016.
8
Clinical and angiographic evaluation of the resolute zotarolimus-eluting coronary stent in Japanese patients – long-term outcome in the RESOLUTE Japan and RESOLUTE Japan small vessel study.日本患者中雷帕霉素洗脱冠状动脉支架的临床和血管造影评估——RESOLUTE日本研究及RESOLUTE日本小血管研究的长期结果
Circ J. 2015;79(1):96-103. doi: 10.1253/circj.CJ-14-0836. Epub 2014 Nov 27.
9
The XIENCE nano everolimus eluting coronary stent system for the treatment of small coronary arteries: the SPIRIT Small Vessel trial.依维莫司洗脱XIENCE 纳米冠状动脉支架系统治疗小血管病变：SPIRIT 小血管试验
Catheter Cardiovasc Interv. 2012 Oct 1;80(4):546-53. doi: 10.1002/ccd.23397. Epub 2012 Jan 12.
10
Small coronary vessel angioplasty: outcomes and technical considerations.小冠状动脉血管成形术：结果与技术考量
Vasc Health Risk Manag. 2010 Oct 21;6:915-22. doi: 10.2147/VHRM.S8161.
Zotero 插件